Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 9Myeloid 5Lymphoid 3Classical hematology 3Sarcoma 1Plasma cell 1CNS 1

Conditions

Gliosarcoma 8Glioblastoma 8Central Nervous System Neoplasms 8Sarcoma 7Brain Neoplasms 6Glioma 5Astrocytoma 4Osteosarcoma 3Oligodendroglioma 3Neuroectodermal Tumors, Primitive 2Neuroblastoma 2Medulloblastoma 2AIDS-related Kaposi sarcoma 2Wilms Tumor 1Urinary Bladder Neoplasms 1Urethral Neoplasms 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Sarcoma, Kaposi 1Sarcoma, Ewing 1Sarcoma, Endometrial Stromal 1Salivary Gland Neoplasms 1Rhabdomyosarcoma 1Retinoblastoma 1Recurrent Uterine Corpus Sarcoma 1Rectal Neoplasms 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pinealoma 1Pancreatic Neoplasms 1

Interventions

Cyclophosphamide 48fludarabine phosphate 28Filgrastim 27Radiotherapy 26Antilymphocyte Serum 26Busulfan 24Cyclosporine 23Peripheral Blood Stem Cell Transplantation 19Mycophenolic Acid 18Cord Blood Stem Cell Transplantation 17Methylprednisolone 16Methotrexate 16Melphalan 15Etoposide 15Tacrolimus 12Whole-Body Irradiation 11Cytarabine 9Thiotepa 6Vincristine 5Psychiatric Rehabilitation 5sargramostim 4aldesleukin 4Sirolimus 4Leucovorin 4Granulocyte Colony-Stimulating Factor 4fludarabine 3Prednisone 3Early Intervention, Educational 3Daunorubicin 3glucarpidase 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia × Thalidomide × Sarcoma × Clear all
NCT00357500 2014-10-01

Etoposide, Cyclophosphamide, Thalidomide, Celecoxib, and Fenofibrate in Relapsed or Progressive Cancer

Dana-Farber Cancer Institute

Phase 2 Completed
101 enrolled 10 charts
CNSLymphoidOther hematologic neoplasmSarcoma

Leukemia, Lymphoma, Neuroblastoma, Sarcoma, Central Nervous System Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡